Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-11-06, Stock:ABBV, The news for the past five days is as follows:
2020-10-30: NEWS1: AbbVie Earnings Top Views On Rising Humira Sales.NEWS2: How AbbVie Beat Expectations in Q3.NEWS3: AbbVie Stock Is Rising Because Earnings Got a Botox Shot.NEWS4: Analyst Report: AbbVie Inc..NEWS5: AbbVie (ABBV) Beats on Q3 Earnings & Sales, Ups 2020 Guidance.NEWS6: AbbVie Posts Stronger-Than-Expected Earnings as Humira Sales Rise 4%.NEWS7: AbbVie (ABBV) Q3 Earnings and Revenues Top Estimates.NEWS8: AbbVie: Q3 Earnings Insights.NEWS9: AbbVie beats earnings expectations, raises its outlook and boosts dividend.NEWS10: AbbVie raises profit outlook on Botox recovery signs, new drugs growth.NEWS11: AbbVie raises 2020 profit forecast as COVID-19 hit eases.NEWS12: AbbVie Reports Third-Quarter 2020 Financial Results.NEWS13: AbbVie, Inc. to Host Earnings Call.NEWS14: 2 No-Brainer Dividend Stocks Yielding More Than 4%.
2020-11-02: NEWS1: Neurocrine (NBIX) to Report Q3 Earnings: What's in Store?.NEWS2: Company News for Nov 2, 2020.NEWS3: Morning Bell With Jim Cramer: Alphabet Had the Best Quarter.NEWS4: Cheap Growth Is Hard to Find. Here Are 9 Stocks to Consider..NEWS5: 3 Top Stocks With High Dividend Yields.NEWS6: 3 Dividend Stocks to Supplement Your Social Security.NEWS7: These 4 Companies Boosted Their Dividends This Week.
2020-11-03: NEWS1: 3 ‘Strong Buy’ Stocks With at Least 5% Dividend Yield.NEWS2: Bristol Myers Says Its Psoriasis Drug Outperformed Amgen’s Otezla.
2020-11-04: NEWS1: AbbVie Shares Soar on 3rd-Quarter Results, Bright Outlook.NEWS2: Republican Hold On Senate Seen As Plus For Drug Companies.
2020-11-05: NEWS1: AbbVie to Highlight Blood Cancer Leadership and Advancing Oncology Pipeline at the ASH 62ND Annual Meeting.NEWS2: AbbVie (ABBV) in Focus: Stock Moves 7.4% Higher.NEWS3: Analyst Report: AbbVie Inc..

Answer: Decrease